U.S. markets closed

  • S&P 500

    4,369.55
    +48.73 (+1.13%)
     

  • Dow 30

    34,870.16
    +448.26 (+1.30%)
     

  • Nasdaq

    14,701.92
    +142.12 (+0.98%)
     

  • Russell 2000

    2,280.00
    +48.32 (+2.17%)
     

  • Crude Oil

    74.63
    +1.69 (+2.32%)
     

  • Gold

    1,808.60
    +8.40 (+0.47%)
     

  • Silver

    26.18
    +0.20 (+0.76%)
     

  • EUR/USD

    1.1881
    +0.0028 (+0.24%)
     

  • 10-Yr Bond

    1.3560
    +0.0680 (+5.28%)
     

  • GBP/USD

    1.3902
    +0.0120 (+0.87%)
     

  • USD/JPY

    110.0290
    +0.2670 (+0.24%)
     

  • BTC-USD

    33,921.82
    +493.26 (+1.48%)
     

  • CMC Crypto 200

    826.23
    +9.44 (+1.16%)
     

  • FTSE 100

    7,121.88
    +91.22 (+1.30%)
     

  • Nikkei 225

    27,940.42
    -177.58 (-0.63%)
     

PCT, ATER & DNMR Final Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / July 11, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

PureCycle Technologies, Inc. (NASDAQ:PCT)
Class Period: November 16, 2020 and May 5, 2021
Deadline: July 12, 2021
For more info: www.bgandg.com/pct

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (2) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (3) PureCycle's financial projections are baseless; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.

Aterian, Inc. (NASDAQ:ATER)
Class Period: December 1, 2020 and May 3, 2021
Deadline: July 12, 2021
For more info: www.bgandg.com/ater

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) the Company's organic growth is plummeting; (2) the Company's recent, self-lauded acquisitions were overpayments for flawed assets from questionable sources; (3) Aterian's purported artificial intelligence software is a flawed product that lacks customer interest; (4) Aterian uses rebate programs and paid or artificial reviews to pump up their product offerings; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times.

Danimer Scientific Inc. (NYSE:DNMR)
Class Period: October 28, 2020 and May 4, 2021
Deadline: July 13, 2021
For more info: www.bgandg.com/dnmr

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Danimer had deficient internal controls; (2) as a result, the Company had misrepresented, inter alia, its operations' size and regulatory compliance; (3) Defendants had overstated Nodax's biodegradability, particularly in oceans and landfills; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/654919/PCT-ATER-DNMR-Final-Deadlines-Bronstein-Gewirtz-Grossman-LLC-Reminds-Investors-of-Class-Actions

Recommended Stories

  • 7 Super-Safe Dividend Stock Performers to Buy

    In most cases, taking longshot bets in the market don’t pan out. However, for those brave contrarians that bought publicly traded securities during the initial onslaught of the novel coronavirus pandemic, they managed to accrue incredible profitability. Many onlookers quickly followed with their own money, making the case for buying super-safe dividend stocks less appealing than they already were. Admittedly, with the very strong showing for the June jobs report, the case for being defensive has

  • Dow Jones Futures: Will Virgin Galactic Stock Rocket After Branson Trip? Roku Leads 8 Stocks Near Buys In Market Rally

    Roku, AMD are near buys in the market rally. Tesla updated FSD Beta. A Virgin Galactic flight with billionaire Richard Branson successfully reached space.

  • 7 Technology Stocks With Terrific Technicals to Buy Right Now

    Tech stocks have been on a roller coaster lately. While some continued to chug to new all-time highs, others suffered a brutal decline amid a nasty bear market. However, many names have emerged with stronger chart setups as a result. Many people only prefer technical analysis or fundamental analysis. However, a blend of the two usually works the best. Fundamental analysis may struggle with tech stocks when it comes to the valuation. While the valuations can be high, I like to look for high-quali

  • Is It Too Late to Buy NVIDIA Stock?

    NVIDIA (NASDAQ: NVDA) shareholders have been benefiting mightily from the ongoing chip shortage, as well as from the popularity of the company's offerings for GPU-based applications. The magnitude of that surge has plenty of investors questioning whether there's still a chance to buy in, or if they have essentially missed out on their opportunity to profit from this particular rally. Let's take a closer look at NVIDIA and attempt to provide an answer.

  • These Stocks Will See Sales More Than Double in 2022, According to Wall Street

    Since the end of the Great Recession, Wall Street and investors have been focused on growth stocks. Historically low lending rates and ongoing quantitative easing from the Federal Reserve have allowed fast-paced companies to borrow cheaply and accelerate their sales growth. As you can imagine, a lot of companies are delivering strong double-digit, or even triple-digit, sales growth in 2021 as the U.S. and global economy bounce back from the coronavirus pandemic.

  • Look to Buy Palantir, Since PLTR Stock Won’t Stay Down for Long

    Palantir (NYSE:PLTR) stock has fallen in July by about 15% month-to-date, despite being in the green today. But like a few other stocks taking some hits, PLTR stock is presenting investors with a short-term purchasing opportunity. Source: Ascannio / Shutterstock.com Palantir is the most technologically advanced data analytics platform provider in the world. And that alone sets them apart as top tog in an industry set for enormous growth. But the business has also been on fire lately, and over th

  • Is it Time to Buy the S&P 500's Worst Performing Dividend Giants?

    Sure, a slumping stock price might indicate a faltering business that investors might want to avoid. The declines that Clorox (NYSE: CLX), Kimberly Clark (NYSE: KMB), and Intel (NASDAQ: INTC) have posted over that time might set investors up for impressive returns. Kimberly Clark, like its chief rival Procter & Gamble (P&G), had a strong pandemic year as organic sales growth accelerated to 6% from 4% in 2019.

  • Big Investor Bought Apple and Chinese EV Stocks NIO and Li Auto. Here’s What It Sold.

    DNB Asset Management bought more Apple and NIO shares, started a stake in Li Auto, and halved an investment in Intel.

  • 4 Stocks That Can Turn $100,000 Into $500,000 by 2030

    These game-changing stocks have the potential to turn a large sum of cash into a life-changing amount of money.

  • 3 Stocks to Watch Amid the China DiDi Selloff

    Chinese ride-hailing company DiDi Global (NYSE: DIDI) has had an eventful public debut -- its shares have fallen by 20% just days after it completed its initial public offering. The stock plunged after Chinese regulators ordered DiDi's app removed from app stores and told the company to cease new user registrations while they conduct a review of its data-collection practices. The Chinese government is also reportedly considering new rules that would allow it to block Chinese companies from listing overseas and increase its regulatory oversight of their business activities.

  • 3 Top Biotech Stocks to Buy in July

    Over the past five years, biotech stocks have somewhat underperformed the S&P 500 benchmark. Controversies regarding drug pricing, the rising cost of innovation in medicine, and increased generic competition have all been chipping away at companies' bottom lines in the sector. Let's have a look at three such players -- Pfizer (NYSE: PFE), Regeneron Pharmaceuticals (NASDAQ: REGN), and Bayer (OTC: BAYR.Y) -- and why they are fantastic choices for investors on the hunt for value.

  • 3 Dividend Stocks I'd Buy Right Now Without Any Hesitation

    Here are three dividend stocks I'd buy right now without any hesitation. Brookfield Renewable has delivered an annualized total return of close to 18% over the last two decades. Part of the appeal of Brookfield Renewables is its strong dividend.

  • Banks Are About to Kick Off Earnings Season. Keep an Eye on Citigroup.

    Banks have proven they have a solid foundation, but the next leg of growth is more uncertain. Here’s what you need to know.

  • Why It Might Not Make Sense To Buy AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend

    Readers hoping to buy AbbVie Inc. ( NYSE:ABBV ) for its dividend will need to make their move shortly, as the stock is...

  • A Stock Market Crash Is Likely: 3 Winning Stocks to Buy When It Happens

    A steep market decline would be the perfect opportunity to put your money to work in these highly successful companies.

  • Strong, Positive Catalysts Make GE Stock a Buy on Weakness

    The commercial aviation sector is rebounding dramatically and multiple, highly reputable analysts are issuing bullish notes on General Electric (NYSE:GE), making GE stock attractive. Source: Sundry Photography / Shutterstock.com Additionally, GE is likely to benefit over the longer term from federal spending initiatives. InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Aviation Sector Is About to Boom In the U.S. and many other countries, domestic leisure air travel has come ba

  • Coinbase Valuation Attractive; On Pace for Record Quarter

    In the current days of high and sometimes absurd valuations, it can be a burdening task to find a company worthy of a long-term investment. Particularly, it's difficult to find one that can provide significant upside, is a large cap stock, and generally has a high trading volume. Today, that stock is Coinbase Global, Inc. (COIN), as its price has dropped on par with Bitcoin’s since the company’s IPO mid-April. (See Coinbase stock charts on TipRanks) Reporting on this growth potential is Owen Lau

  • These 2 Under-the-Radar Stocks Could Double (or More), Say Analysts

    Not every sound stock choice makes waves and headlines in the markets. That should be obvious – one reason the market’s giants draw so many investors is a combination of social pressure, ‘fear of missing out,’ reinforced by the news dominance those very giants generate. But history’s most successful investors kept their portfolios diversified, and that includes investments in lesser-known stocks. These are stocks that – for whatever reason – have slipped ‘under the radar’ – they haven’t picked u

  • Commodity Boom Dwarfs Oil Spat as Emerging Markets Set to Win

    (Bloomberg) -- For some of the world’s biggest money managers, the OPEC+ oil-price feud is little more than a sideshow when it comes to emerging markets.Investors and strategists at JPMorgan Chase & Co. and Goldman Sachs Group Inc. say the post-pandemic economic recovery will stoke demand for raw materials across the board, buoying commodity-sensitive assets regardless of whether a crude accord is reached. Russia and Colombia are among the countries that stand to benefit in particular, according

  • Pelosi Husband’s Tech Stock Spotlights Law on Lawmaker Trades

    (Bloomberg) -- Paul Pelosi’s multi-million-dollar win on Alphabet Inc. stock in the week before a U.S. House committee publicly considered legislation affecting technology giants has drawn renewed attention to a decade-old law governing lawmakers’ trades that some outside experts say should be changed.House Speaker Nancy Pelosi’s husband acted legally and within the bounds of the 2012 Stop Trading on Congressional Knowledge, or Stock, Act when he exercised options to acquire more shares of the p